Literature DB >> 17123106

A comparison of pathomolecular markers of fibrosis and morphology in kidney from autopsies of African Americans and whites.

Betty Pat1, Michael D Hughson, Jennifer L Nicol, Wendy E Hoy, Glenda C Gobe.   

Abstract

African Americans have an increased incidence of chronic kidney disease (CKD) due to hypertension and arteriosclerosis and increased death due to coronary artery disease, compared with whites. The pathogenesis of CKD involves the increased presence and activation of myofibroblasts and macrophages, promotion of tubulointerstitial fibrosis, and effects of tubulointerstitial cell mitosis and apoptosis. We hypothesized that increased risk of hypertensive vascular disease may be identified by renal pathomolecular markers that are associated with progressive CKD. Renal sections were available from 50 autopsies of 33 African Americans (55% males) and 17 whites (76% males) undergoing forensic autopsy for unexpected death. Sclerotic glomeruli, severity of cortical fibrosis, and renal arteriolosclerosis, total glomerular number (N (glom)), average glomerular volume (V (glom)), birth weights, and blood pressure were known. Presence and locality of markers for myofibroblasts (alpha-SMA), macrophages (CD68), collagen, pro-fibrotic transforming growth factor-beta1 were scored in renal autopsies, and tubulointerstitial apoptosis was recorded. The results demonstrated a strong positive correlation between age, cortical fibrosis and alpha-SMA (p<0.05), and between CD68 and hypertension and coronary artery disease (p<0.05). The findings confirm the role of myofibroblasts and macrophages in pathogenesis of human CKD. However, the markers showed no significant relationships to V (glom), N (glom), birth weight, or race.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123106     DOI: 10.1007/s00428-006-0335-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

1.  Glomerular size and glomerulosclerosis in Australian aborigines.

Authors:  R J Young; W E Hoy; P Kincaid-Smith; A E Seymour; J F Bertram
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

2.  Macrophage apoptosis in rat crescentic glomerulonephritis.

Authors:  H Y Lan; H Mitsuhashi; Y Y Ng; D J Nikolic-Paterson; N Yang; W Mu; R C Atkins
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 3.  Anatomical methods in cell death.

Authors:  J F Kerr; G C Gobé; C M Winterford; B V Harmon
Journal:  Methods Cell Biol       Date:  1995       Impact factor: 1.441

Review 4.  Fetal nutrition and cardiovascular disease in adult life.

Authors:  D J Barker; P D Gluckman; K M Godfrey; J E Harding; J A Owens; J S Robinson
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

5.  Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.

Authors:  B Rodríguez-Iturbe; H Pons; Y Quiroz; K Gordon; J Rincón; M Chávez; G Parra; J Herrera-Acosta; D Gómez-Garre; R Largo; J Egido; R J Johnson
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

6.  Collagenofibrotic glomerulopathy with a widespread expression of type-V collagen.

Authors:  Hiroyuki Morita; Takeshi Hasegawa; Toshinari Minamoto; Yoshio Oda; Kiyoko Inui; Hironori Tayama; Naoyuki Nakao; Yasushi Nakamoto; Terukuni Ideura; Ashio Yoshimura
Journal:  Virchows Arch       Date:  2002-12-13       Impact factor: 4.064

7.  Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia.

Authors:  S E Thomas; S Anderson; K L Gordon; T T Oyama; S J Shankland; R J Johnson
Journal:  J Am Soc Nephrol       Date:  1998-02       Impact factor: 10.121

Review 8.  Renal fibrosis: insights into pathogenesis and treatment.

Authors:  A M el Nahas; E C Muchaneta-Kubara; M Essawy; O Soylemezoglu
Journal:  Int J Biochem Cell Biol       Date:  1997-01       Impact factor: 5.085

9.  Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade.

Authors:  H Peters; W A Border; N A Noble
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

10.  Heterogeneity of glomerular size in normal donor kidneys: impact of race.

Authors:  R Abdi; D Slakey; D Kittur; L C Racusen
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860

View more
  4 in total

1.  Soy protein prevents renal damage in a fructose-induced model of metabolic syndrome via inhibition of NF-kB in male rats.

Authors:  Nallasamy Palanisamy; Carani Venkataraman Anuradha
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

2.  Physiological stress increases renal injury in eNOS-knockout mice.

Authors:  Mildred A Pointer; Geraldine Daumerie; LaKessha Bridges; Sadiqa Yancey; Kelly Howard; Wendell Davis; Paul Huang; Joseph Loscalzo
Journal:  Hypertens Res       Date:  2011-12-15       Impact factor: 3.872

Review 3.  Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.

Authors:  Glenda C Gobe; Christudas Morais; David A Vesey; David W Johnson
Journal:  J Nephropathol       Date:  2013-07-01

4.  Effect of Erythropoietin on Postresuscitation Renal Function in a Swine Model of Ventricular Fibrillation.

Authors:  Charalampos Pantazopoulos; Nicoletta Iacovidou; Evangelia Kouskouni; Paraskevi Pliatsika; Apostolos Papalois; Georgios Kaparos; Dimitrios Barouxis; Panagiotis Vasileiou; Pavlos Lelovas; Olympia Kotsilianou; Ioannis Pantazopoulos; Georgios Gkiokas; Clara Garosa; Gavino Faa; Theodoros Xanthos
Journal:  Biomed Res Int       Date:  2016-10-25       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.